Literature DB >> 23064391

Otolithic membrane damage in patients with endolymphatic hydrops and drop attacks.

Audrey P Calzada1, Ivan A Lopez, Gail Ishiyama, Akira Ishiyama.   

Abstract

OBJECTIVES: 1. Evaluate the otolithic membrane in patients with endolymphatic hydrops (EH) and vestibular drop attacks (VDA) undergoing ablative labyrinthectomy. 2. Correlate intraoperative findings to archival temporal bone specimens of patients with EH. STUDY
DESIGN: Retrospective case review.
SETTING: Tertiary referral center. SPECIMEN SOURCE: 1. Patients undergoing labyrinthectomy for incapacitating Ménière's disease (MD), delayed EH, VDA, or acoustic neuroma (AN) between 2004 and 2011. 2. Archival temporal bone specimens of patients with MD.
INTERVENTIONS: Ablative labyrinthectomy. MAIN OUTCOME MEASURES: Examination of the utricular otolithic membrane.
RESULTS: The otolithic membrane of the utricle was evaluated intraoperatively in 28 patients undergoing labyrinthectomy. Seven (25%) had a history of VDA, 6 (21%) had delayed EH, 9 (32%) had MD, and 6 (21%) had AN. All patients with VDA showed evidence of a disrupted utricular otolithic membrane, whereas only 50% and 56% of patients with delayed EH and MD, respectively, demonstrated otolithic membrane disruption (p = 0.051). None of the patients with AN showed otolithic membrane disruption (p = 0.004). The mean thickness of the otolithic membrane in 5 archival temporal bone MD specimens was 11.45 micrometers versus 38 micrometers in normal specimens (p = 0.001).
CONCLUSION: The otolithic membrane is consistently damaged in patients with VDA. In addition, there is a significantly higher incidence of otolithic membrane injury in patients with MD and delayed EH compared with patients without hydrops, suggesting that the underlying pathophysiology in VDA results from injury to the otolithic membrane of the saccule and utricle, resulting in free-floating otoliths and atrophy.

Entities:  

Mesh:

Year:  2012        PMID: 23064391      PMCID: PMC5358090          DOI: 10.1097/MAO.0b013e318271c48b

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  25 in total

1.  Targeted disruption of otog results in deafness and severe imbalance.

Authors:  M C Simmler; M Cohen-Salmon; A El-Amraoui; L Guillaud; J C Benichou; C Petit; J J Panthier
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

Review 2.  Assembly of the otoconia complex to the macular sensory epithelium of the vestibule.

Authors:  Yunxia Wang Lundberg; Xing Zhao; Ebenezer N Yamoah
Journal:  Brain Res       Date:  2006-04-04       Impact factor: 3.252

3.  Conservative management of Tumarkin's otolithic crisis.

Authors:  V D Janzen; R D Russell
Journal:  J Otolaryngol       Date:  1988-12

4.  Diagnosis and management of drop attacks of vestibular origin: Tumarkin's otolithic crisis.

Authors:  F O Black; M Z Effron; D S Burns
Journal:  Otolaryngol Head Neck Surg       Date:  1982 Mar-Apr       Impact factor: 3.497

5.  Drop attacks in older patients secondary to an otologic cause.

Authors:  G Ishiyama; A Ishiyama; K Jacobson; R W Baloh
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

6.  [Vestibular drop attacks or Tumarkin's otolithic crisis in patients with Meniere's disease].

Authors:  C Morales Angulo; J Gallo-Terán
Journal:  Acta Otorrinolaringol Esp       Date:  2005-12

7.  Gene targeting reveals the role of Oc90 as the essential organizer of the otoconial organic matrix.

Authors:  Xing Zhao; Hua Yang; Ebenezer N Yamoah; Yunxia Wang Lundberg
Journal:  Dev Biol       Date:  2007-01-12       Impact factor: 3.582

8.  Drop attacks in Menière's disease.

Authors:  L M Odkvist; J Bergenius
Journal:  Acta Otolaryngol Suppl       Date:  1988

9.  Drop attacks and vertigo secondary to a non-meniere otologic cause.

Authors:  Gail Ishiyama; Akira Ishiyama; Robert W Baloh
Journal:  Arch Neurol       Date:  2003-01

10.  Vestibular drop attack secondary to Meniere's disease results from unstable otolithic function.

Authors:  Hidenori Ozeki; Shinichi Iwasaki; Toshihisa Murofushi
Journal:  Acta Otolaryngol       Date:  2008-08       Impact factor: 1.494

View more
  9 in total

Review 1.  [Otoconia : Current aspects of research].

Authors:  L E Walther
Journal:  HNO       Date:  2016-10       Impact factor: 1.284

2.  Spatiotemporal differences in otoconial gene expression.

Authors:  Yinfang Xu; Yan Zhang; Yunxia Wang Lundberg
Journal:  Genesis       Date:  2016-11-12       Impact factor: 2.487

3.  Do patients with Ménière's disease have attacks of syncope?

Authors:  Ilmari Pyykkö; Vinaya Manchaiah; Jing Zou; Hilla Levo; Erna Kentala
Journal:  J Neurol       Date:  2017-03-20       Impact factor: 4.849

4.  Otopetrin-2 Immunolocalization in the Human Macula Utricle.

Authors:  Ivan A Lopez; Gail Ishiyama; Dora Acuna; Akira Ishiyama
Journal:  Ann Otol Rhinol Laryngol       Date:  2019-06       Impact factor: 1.547

5.  Vestibular drop attacks in Ménière's disease and its association with migraine.

Authors:  Ilmari Pyykkö; Nora Pyykkö; Vinaya Manchaiah
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-17       Impact factor: 2.503

6.  Principles of calcite dissolution in human and artificial otoconia.

Authors:  Leif Erik Walther; Alexander Blödow; Jana Buder; Rüdiger Kniep
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

7.  Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study.

Authors:  Bo Liu; Yangming Leng; Renhong Zhou; Jingjing Liu; Dongdong Liu; Su-Lin Zhang; Wei-Jia Kong
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

8.  Intermediate Latency-Evoked Potentials of Multimodal Cortical Vestibular Areas: Galvanic Stimulation.

Authors:  Stefan Kammermeier; Arun Singh; Kai Bötzel
Journal:  Front Neurol       Date:  2017-11-03       Impact factor: 4.003

9.  Oxidative Stress in the Blood Labyrinthine Barrier in the Macula Utricle of Meniere's Disease Patients.

Authors:  Gail Ishiyama; Jacob Wester; Ivan A Lopez; Luis Beltran-Parrazal; Akira Ishiyama
Journal:  Front Physiol       Date:  2018-09-03       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.